Lorenzo Spaggiari
Overview
Explore the profile of Lorenzo Spaggiari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
455
Citations
4913
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Volpe S, Vincini M, Zaffaroni M, Gaeta A, Raimondi S, Piperno G, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075755
An Early-Stage Non-Small Cell Lung Cancer (ES-NSCLC) patient candidate for stereotactic body radiotherapy (SBRT) may start their treatment without a histopathological assessment, due to relevant comorbidities. The aim of this...
2.
de Marinis F, Ardizzoni A, Attili I, Bonanno L, Bria E, Cortinovis D, et al.
Curr Oncol
. 2025 Feb;
32(2).
PMID: 39996910
Background: Immunotherapy (IO)-based strategies have been demonstrated to significantly prolong survival in the perioperative setting of non-oncogene-addicted non-small cell lung cancer (NSCLC). The adoption of such strategies in clinical practice...
3.
Bertolaccini L, Santucci C, La Vecchia C, Toffolutti F, Corso G, Spaggiari L, et al.
Eur J Cancer Prev
. 2025 Feb;
PMID: 39932541
Lung cancer is the leading cause of cancer-related mortality worldwide, and understanding its pathological patterns and trends is of interest for clinical and public health interventions. This study investigates the...
4.
Catania C, Manglaviti S, Zucali P, Perrino M, Ruffini E, Di Tommaso L, et al.
Cancers (Basel)
. 2025 Jan;
17(2.
PMID: 39858021
Background: thymic basaloid carcinoma (BTC) is an extremely rare tumor, and very little data are available on BTC's biology, clinical behavior, drug sensitivity, and patient outcomes. Methods: We performed a...
5.
Casiraghi M, Orlandi R, Bertolaccini L, Mazzella A, Girelli L, Diotti C, et al.
J Clin Med
. 2025 Jan;
14(1.
PMID: 39797184
Postoperative physiotherapy is a cornerstone of Enhanced Recovery After Surgery (ERAS) programs, especially following lung resection. Despite its importance, the literature lacks clear recommendations and guidelines, particularly regarding the role...
6.
Bertolaccini L, Bardoni C, Caffarena G, Chiari M, Diotti C, Mazzella A, et al.
Eur J Cancer Prev
. 2025 Jan;
PMID: 39786538
Leading societies have established guidelines that vary significantly regarding recommendations for the surgical management of pulmonary carcinoids (PC). We aimed to assess current guidelines and recommendations for PC surgical management,...
7.
Lombardi M, DErcole M, Midolo De Luca V, Chiari M, Spaggiari L, Bertolaccini L
Heliyon
. 2025 Jan;
11(1):e41128.
PMID: 39758364
This case report explores the therapeutic impact of SMARCA4 loss in a 63-year-old female patient with a history of smoking, hypertension, hypercholesterolemia, and prior surgeries for breast and pancreatic carcinomas,...
8.
Bertolaccini L, Piva V, Mazzella A, Casiraghi M, Felisi M, Spaggiari L
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597896
Thoracic surgery is deeply intertwined with the principles of physics, which govern the tools and techniques used in various procedures. A thorough understanding of these principles is essential for the...
9.
Gallina F, Cecere F, Taje R, Bertolaccini L, Casiraghi M, Spaggiari L, et al.
Eur J Cardiothorac Surg
. 2024 Nov;
66(5).
PMID: 39531280
Objectives: This study aimed to evaluate the predictive and prognostic factors in clinical stage I, anaplastic lymphoma kinase (ALK)-rearranged lung adenocarcinoma following radical surgery. Additionally, it sought to compare these...
10.
Bertolaccini L, Ciani O, Lucchi M, Zaraca F, Bertani A, Crisci R, et al.
JMIR Res Protoc
. 2024 Oct;
13:e67629.
PMID: 39471369
[This corrects the article DOI: 10.2196/57183.].